On the correlation between fracture toughness and crash resistance of advanced high strength steels

Autor: Frómeta, D., Lara, A., Molas, S., Casellas, D., Rehrl, J., Suppan, C., Larour, P., Calvo, J.

Publikováno v: In Engineering Fracture Mechanics January 2019 205:319-332

Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

Autor: Wimmer K; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Vienna, Austria. kerstin.wimmer@meduniwien.ac.at.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. kerstin.wimmer@meduniwien.ac.at., Hlauschek D; Austrian Breast & Colorectal Cancer Study Group, Vienna, Austria., Balic M; Department of Oncology, Medical University of Graz, Graz, Austria., Pfeiler G; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria., Greil R; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.; Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.; Cancer Cluster Salzburg, Salzburg, Austria., Singer CF; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria., Halper S; Department of Surgery, Regional Hospital Wiener Neustadt, Wiener Neustadt, Austria., Steger G; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria., Suppan C; Department of Oncology, Medical University of Graz, Graz, Austria., Gampenrieder SP; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.; Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.; Cancer Cluster Salzburg, Salzburg, Austria., Helfgott R; Department of Surgery, Ordensklinikum Linz - Sisters of Charity, Linz, Austria., Egle D; Department of Gynaecology, Medical University Innsbruck, Innsbruck, Austria., Filipits M; Center for Cancer Research, Medical University of Vienna, Vienna, Austria., Jakesz R; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Sölkner L; Austrian Breast & Colorectal Cancer Study Group, Vienna, Austria., Fesl C; Austrian Breast & Colorectal Cancer Study Group, Vienna, Austria., Gnant M; Austrian Breast & Colorectal Cancer Study Group, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Fitzal F; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (2), pp. 227-239. Date of Electronic Publication: 2024 Jan 25.

Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.

Autor: Suppan C; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Graf R; Institute of Human Genetics, Diagnostic and Research Center for Molecular Biomedicine (Austria), Medical University of Graz, Graz, Austria., Jahn S; Institute of Pathology, Medical University of Graz, Graz, Austria., Zhou Q; Institute of Human Genetics, Diagnostic and Research Center for Molecular Biomedicine (Austria), Medical University of Graz, Graz, Austria., Klocker EV; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Bartsch R; Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria., Terbuch A; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Kashofer K; Institute of Pathology, Medical University of Graz, Graz, Austria., Regitnig P; Institute of Pathology, Medical University of Graz, Graz, Austria., Lindenmann J; Division of Thoracic Surgery and Hyperbaric Surgery, Department of Surgery, Medical University of Graz, Graz, Austria., Posch F; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Gerritsmann H; Novartis Pharma GmbH, Jakov-Lind-Straße 5, 1020, Vienna, Austria., Jost PJ; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Department of Medicine III, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany., Heitzer E; Institute of Human Genetics, Diagnostic and Research Center for Molecular Biomedicine (Austria), Medical University of Graz, Graz, Austria.; BioTechMed-Graz, Graz, Austria.; Christian Doppler Laboratory for Liquid Biopsies for Early Detection of Cancer, Graz, Austria., Dandachi N; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. nadia.dandachi@medunigraz.at.; Research Unit Epigenetic and Genetic Cancer Biomarkers, Medical University of Graz, Graz, Austria. nadia.dandachi@medunigraz.at., Balic M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. marija.balic@medunigraz.at.; Research Unit Translational Breast Cancer, Medical University of Graz, Graz, Austria. marija.balic@medunigraz.at.

Publikováno v: British journal of cancer [Br J Cancer] 2022 Feb; Vol. 126 (3), pp. 456-463. Date of Electronic Publication: 2021 Nov 09.

2261P A head-to-head comparison for detecting PIK3CA mutations in circulating tumor DNA of advanced HR+/HER2- breast cancer patients

Autor: Dandachi, N., Graf, R., Pancheri, L., Dobrić, N., Klocker, E.V., Suppan, C., Jost, P.J., Heitzer, E., Balic, M.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S1162-S1163

Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12.

Autor: Beltran-Bless AA; Division of Medical Oncology, The Ottawa Hospital Cancer Centre and University of Ottawa, Ottawa, Ontario, Canada., Clemons MJ; Division of Medical Oncology, The Ottawa Hospital Cancer Centre and University of Ottawa, Ottawa, Ontario, Canada; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Fesl C; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria., Greil R; Salzburg Cancer Research Institute; 3d Medical Department, Paracelsus Medical University Salzburg; Cancer Cluster Salzburg, Austria., Pond GR; Ontario Clinical Oncology Group, Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Balic M; Division of Oncology, Department of Internal Medicine and Comprehensive Cancer Center, Medical University of Graz, Graz, Austria., Vandermeer L; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Bjelic-Radisic V; Breast Unit, Helios University Hospital Wuppertal, Wuppertal Germany, University Witten/Herdecke, Germany; And Department of Gynecology and Obstetrics, Medical University of Graz, Graz, Austria., Singer CF; Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Steger GG; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria., Helfgott R; Department of Surgery and Breast Health Center, Ordensklinikum Linz, Linz, Austria., Egle D; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria., Sölkner L; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria., Gampenrieder SP; Salzburg Cancer Research Institute; 3d Medical Department, Paracelsus Medical University Salzburg; Cancer Cluster Salzburg, Austria., Kacerovsky-Strobl S; Breast Health Center, St. Francis Hospital Vienna, Vienna, Austria., Suppan C; Division of Oncology, Department of Internal Medicine and Comprehensive Cancer Center, Medical University of Graz, Graz, Austria., Ritter M; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria., Rinnerthaler G; Ontario Clinical Oncology Group, Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Pfeiler G; Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Fohler H; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria., Hlauschek D; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria., Hilton J; Division of Medical Oncology, The Ottawa Hospital Cancer Centre and University of Ottawa, Ottawa, Ontario, Canada; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Gnant M; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Electronic address: michael.gnant@meduniwien.ac.at.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Feb; Vol. 180, pp. 108-116. Date of Electronic Publication: 2022 Dec 10.